Longitudinal and age trends of metabolic syndrome and its risk factors: The Family Heart Study

Nutrition and Metabolism

Volumn 3, Issue , 2006, Pages

  Kraja, Aldi T ^a,f   Borecki, Ingrid B ^a   North, Kari ^b   Tang, Weihong ^c   Myers, Richard H ^d   Hopkins, Paul N ^e   Arnett, Donna ^f   Corbett, Jonathan ^a   Adelman, Avril ^a   Province, Michael A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATION PROGRAM; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK FACTOR; TREND STUDY; WAIST CIRCUMFERENCE;

EID: 33845569677     PISSN: 17437075     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-3-41     Document Type: Article

References (28)

1. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002, 17/24:3144-3421.
2. Ford ES, Giles WH: A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003, 26:575-581.
3. Meigs JB: Epidemiology of the metabolic syndrome, 2002. Am J Manag Care 2002, 8:S283-S292.
4. Alexander CM, Landsman PB, Teutsch SM, Haffner SM, Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP): NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003, 52:1210-1214.
5. Kraja AT, Rao DC, Weder AB, Cooper R, Curb JD, Hanis CL, Turner ST, de Andrade M, Hsiung CA, Quertermous T, Zhu X, Province MA: Two major QTLs and several others relate to factors of metabolic syndrome in the Family Blood Pressure Program. Hypertension 2005, 46:751-757.
6. Tang W, Miller MB, Rich SS, North KE, Pankow JS, Borecki IB, Myers RH, Hopkins PN, Leppert M, Arnett DK: Linkage analysis of a composite factor for the multiple metabolic syndrome: the National Heart, Lung, and Blood Institute Family Heart Study. Diabetes 2003, 52:2840-2847.
7. Austin MA, Edwards KL, McNeely MJ, Chandler WL, Leonetti DL, Talmud PJ, Humphries SE, Fujimoto WY: Heritability of multivariate factors of the metabolic syndrome in nondiabetic Japanese Americans. Diabetes 2004, 53:1166-1169.
8. Freeman MS, Mansfield MW, Barrett JH, Grant PJ: Insulin resistance: an atherothrombotic syndrome. The Leeds family study. Thromb Haemost 2003, 89:161-168.
9. Deedwania PC, Volkova N: Current Treatment Options for the Metabolic Syndrome. Curr Treat Options Cardiovasc Med 2005, 7:61-74.
10. Hopkins PN, Heiss G, Ellison RC, Province MA, Pankow JS, Eckfeldt JH, Hunt SC: Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 2003, 108:519-23.
11. Ellison RC, Zhang Y, Wagenknecht LE, Eckfeldt JH, Hopkins PN, Pankow JS, Djoussé L, Carr JJ: Relation of the metabolic syndrome to calcified atherosclerotic plaque in the coronary arteries and aorta. Am J Cardiol 2005, 95:1180-1186.
12. Pankow JS, Heiss G, Evans GW, Sholinsky P, Province MA, Coon H, Ellison RC, Miller MB, Qaqish B: Familial aggregation and genome-wide linkage analysis of carotid artery plaque: the NHLBI family heart study. Hum Hered 2004, 57:80-89.
13. Goldin LR, Camp NJ, Keen KJ, Martin LJ, Moslehi R, Ghosh S, North KE, Wyszynski DF, Blacker D: Analysis of metabolic syndrome phenotypes in Framingham Heart Study families from Genetic Analysis Workshop 13. Genet Epidemiol 2003, 25:S78-S89.
14. Frontini MG, Srinivasan SR, Berenson GS: Longitudinal changes in risk variables underlying metabolic Syndrome X from childhood to young adulthood in female subjects with a history of early menarche: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 2003, 27:1398-1404.
15. Maumus S, Marie B, Siest G, Visvikis-Siest S: A prospective study on the prevalence of metabolic syndrome among healthy French families: two cardiovascular risk factors (HDL cholesterol and tumor necrosis factor-alpha) are revealed in the offspring of parents with metabolic syndrome. Diabetes Care 2005, 28:675-682.
16. Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR, Rao DC, Sprafka JM, Williams R: NHLBI Family Heart Study: objectives and design. Am J Epidemiol 1996, 143:1219-1228.
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
18. Wu J, Kraja AT, Oberman A, Lewis CE, Ellison RC, Arnett DK, Heiss G, Lalouel JM, Turner ST, Hunt SC, Province MA, Rao DC: A summary of the effects of antihypertensive medications on measured blood pressure. Am J Hypertens 2005, 18:935-942.
19. Hunt KJ, Heiss G, Sholinsky PD, Province MA: Familial history of metabolic disorders and the multiple metabolic syndrome: the NHLBI family heart study. Genet Epidemiol 2000, 19:395-409.
20. Rose KM, Arnett DK, Ellison RC, Heiss G: Skip patterns in DINAMAP-measured blood pressure in 3 epidemiological studies. Hypertension 2000, 35:1032-1036.
21. Girman CJ, Rhodes T, Mercuri M, Pyorala K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfield M, 4S Group and the AFCAPS/Tex-CAPS Research Group: The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 93:136-141. 2004 Jan 15
22. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M: The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 2004, 21:52-58.
23. Toplak H: Das Metabolische Syndrom - ein hohes kardiovaskuläres Risiko? Acta Med Aust 2004, 31:63-66.
24. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM: The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003, 26:3153-3159.
25. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004, 110:1245-1250.
26. Sturrock ND, Pound N, Peck GM, Soar CM, Jeffcoate WJ: An assessment of blood pressure measurement in a diabetic clinic using random-zero, semi-automated, and 24-hour monitoring. Diabet Med 1997, 14:370-375.
27. Kuo CS, Hwu CM, Kwok CF, Hsiao LC, Weih MJ, Lee SH, Ho LT: Using semi-automated oscillometric blood pressure measurement in diabetic patients and their offspring. J Diabetes Complications 2000, 14:288-293.
28. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2916.